Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
5 days ago · Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
FDA approves Vertex non-opioid painkiller drug Journavx - CNBC
5 days ago · The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
FDA approves painkiller designed to eliminate risks of addiction ...
4 days ago · 1 of 3 | U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids. The Food and Drug Administration …
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex Pharmaceuticals said.
FDA signs off on Vertex’s non-opioid pain reliever Journavx
4 days ago · Vertex Pharmaceuticals has scored an FDA approval for Journavx (suzetrigine), a non-opioid pain reliever that could usher in a new era of nonaddictive therapy in the indication. …
FDA approves new type of non-opioid pain medication, 1st of
4 days ago · The drug, called Journavx (suzetrigine) and manufactured by biotech company Vertex Pharmaceuticals, is a non-opioid painkiller, which doesn’t have addictive properties, …
New FDA-Approved Painkiller Is a Safer Alternative to Opioids
3 days ago · Journavx, Vertex's new non-opioid painkiller, is an alternative for managing moderate-to-severe acute pain without the risk of addiction. Clinical trials showed it provides …
Vertex: New non-opioid painkiller Journavx approved by US FDA
4 days ago · New drug suzetrigine, known by its brand name Journavx, has been approved to treat moderate to severe pain.
Vertex Announces Positive Results From the VX-548 Phase 3 …
Jan 30, 2024 · Vertex’s approach is to selectively inhibit NaV1.8 using small molecules with the objective of creating a new class of medicines that have the potential to provide effective relief …
Experimental Drug Cuts Off Pain at the Source, Company Says
Jan 30, 2024 · Vertex Pharmaceuticals of Boston announced Tuesday that it had developed an experimental drug that relieves moderate to severe pain, blocking pain signals before they can …